annual total liabilities:
$319.06M+$68.25M(+27.21%)Summary
- As of today (July 27, 2025), NTLA annual total liabilities is $319.06 million, with the most recent change of +$68.25 million (+27.21%) on December 31, 2024.
- During the last 3 years, NTLA annual total liabilities has risen by +$64.84 million (+25.51%).
- NTLA annual total liabilities is now at all-time high.
Performance
NTLA Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$206.24M-$112.81M(-35.36%)Summary
- As of today (July 27, 2025), NTLA quarterly total liabilities is $206.24 million, with the most recent change of -$112.81 million (-35.36%) on March 31, 2025.
- Over the past year, NTLA quarterly total liabilities has dropped by -$17.21 million (-7.70%).
- NTLA quarterly total liabilities is now -35.36% below its all-time high of $319.06 million, reached on December 31, 2024.
Performance
NTLA quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
NTLA Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.2% | -7.7% |
| 3 y3 years | +25.5% | -17.2% |
| 5 y5 years | +395.4% | +207.9% |
NTLA Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +27.2% | -35.4% | +0.1% |
| 5 y | 5-year | at high | +395.4% | -35.4% | +60.0% |
| alltime | all time | at high | >+9999.0% | -35.4% | +255.8% |
NTLA Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $206.24M(-35.4%) |
| Dec 2024 | $319.06M(+27.2%) | $319.06M(+51.4%) |
| Sep 2024 | - | $210.74M(-4.4%) |
| Jun 2024 | - | $220.47M(-1.3%) |
| Mar 2024 | - | $223.45M(-10.9%) |
| Dec 2023 | $250.81M(-11.9%) | $250.81M(+21.8%) |
| Sep 2023 | - | $205.94M(-5.7%) |
| Jun 2023 | - | $218.35M(-3.8%) |
| Mar 2023 | - | $227.05M(-20.2%) |
| Dec 2022 | $284.53M(+11.9%) | $284.53M(+9.6%) |
| Sep 2022 | - | $259.51M(+12.9%) |
| Jun 2022 | - | $229.88M(-7.7%) |
| Mar 2022 | - | $249.03M(-2.0%) |
| Dec 2021 | $254.22M(+70.3%) | $254.22M(+11.6%) |
| Sep 2021 | - | $227.86M(+28.4%) |
| Jun 2021 | - | $177.43M(+3.7%) |
| Mar 2021 | - | $171.02M(+14.6%) |
| Dec 2020 | $149.25M | $149.25M(+15.8%) |
| Sep 2020 | - | $128.94M(-7.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $139.24M(+107.8%) |
| Mar 2020 | - | $66.99M(+4.0%) |
| Dec 2019 | $64.40M(-7.2%) | $64.40M(-9.3%) |
| Sep 2019 | - | $70.98M(-6.1%) |
| Jun 2019 | - | $75.58M(-5.6%) |
| Mar 2019 | - | $80.03M(+15.3%) |
| Dec 2018 | $69.39M(-8.3%) | $69.39M(+19.7%) |
| Sep 2018 | - | $57.96M(-4.1%) |
| Jun 2018 | - | $60.44M(-5.6%) |
| Mar 2018 | - | $64.05M(-15.3%) |
| Dec 2017 | $75.64M(-15.1%) | $75.64M(+3.2%) |
| Sep 2017 | - | $73.32M(-5.3%) |
| Jun 2017 | - | $77.39M(-2.5%) |
| Mar 2017 | - | $79.38M(-10.9%) |
| Dec 2016 | $89.13M(-13.7%) | $89.13M(+6.9%) |
| Sep 2016 | - | $83.34M(-4.2%) |
| Jun 2016 | - | $87.02M(-15.3%) |
| Mar 2016 | - | $102.68M(-0.6%) |
| Dec 2015 | $103.34M(+3203.7%) | $103.34M |
| Dec 2014 | $3.13M | - |
FAQ
- What is Intellia Therapeutics, Inc. annual total liabilities?
- What is the all time high annual total liabilities for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. annual total liabilities year-on-year change?
- What is Intellia Therapeutics, Inc. quarterly total liabilities?
- What is the all time high quarterly total liabilities for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. quarterly total liabilities year-on-year change?
What is Intellia Therapeutics, Inc. annual total liabilities?
The current annual total liabilities of NTLA is $319.06M
What is the all time high annual total liabilities for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high annual total liabilities is $319.06M
What is Intellia Therapeutics, Inc. annual total liabilities year-on-year change?
Over the past year, NTLA annual total liabilities has changed by +$68.25M (+27.21%)
What is Intellia Therapeutics, Inc. quarterly total liabilities?
The current quarterly total liabilities of NTLA is $206.24M
What is the all time high quarterly total liabilities for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high quarterly total liabilities is $319.06M
What is Intellia Therapeutics, Inc. quarterly total liabilities year-on-year change?
Over the past year, NTLA quarterly total liabilities has changed by -$17.21M (-7.70%)